EC Number   |
Recommended Name |
Source Tissue |
Reference |
|---|
   2.1.1.357 | [histone H3]-lysine36 N-dimethyltransferase |
bladder transitional cell carcinoma cell |
- |
753720 |
 2.4.2.3 | uridine phosphorylase |
bladder transitional cell carcinoma cell |
12 weeks after initiation of BBN treatment: higher PyNpase level in superficial cancer and hyperplasia compared to controls, 16 and 20 weeks after initiation of BBN treatment: higher PyNpase level in superficial cancer but not in hyperplasia compared to controls |
692693 |
| 2.4.2.3 | uridine phosphorylase |
bladder transitional cell carcinoma cell |
12, 16 and 20 weeks after initiation of BBN treatment: higher PyNpase level in invasive carcinoma and hyperplasia compared to controls |
692693 |
| 2.4.2.4 | thymidine phosphorylase |
bladder transitional cell carcinoma cell |
higher PyNpase levels in tumor tissue than in normal tissue or tissue adjacent to the tumor, PyNpase levels independent of age, gender, history of recurrence, multiplicity, tumor size, tumor shape, pathological stage (Ta, T1-4), PyNpase levels differ between histological stages being highest in G3, and between papillary versus non-papillary growth pattern, higher PyPnase levels in high-risk group (G3 or Tis or T2) than in low-risk group (primary, single, G1 and Ta) |
692693 |
| 2.7.1.67 | 1-phosphatidylinositol 4-kinase |
bladder transitional cell carcinoma cell |
- |
721967 |
| 3.3.2.10 | soluble epoxide hydrolase |
bladder transitional cell carcinoma cell |
low to high sEH staining |
681501 |
| 3.4.21.B6 | prostasin |
bladder transitional cell carcinoma cell |
- |
707872 |
| 3.5.1.60 | N-(long-chain-acyl)ethanolamine deacylase |
bladder transitional cell carcinoma cell |
- |
752960 |
| 3.5.3.15 | protein-arginine deiminase |
bladder transitional cell carcinoma cell |
moderate expression |
666311 |
